Epirubicin
Drug timelines are a Plus or Pro feature.
111 regulatory and trial events tracked for Epirubicin, covering 2006-06-22 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma [Phase 2]